Analyst Ratings for Aratana Therapeutics (PETX)

PETX Rating Summary

  |   Expand Research on PETX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.8 / 10   Percentile Rank: 65%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/30/2019 Credit Suisse Erin Wright Downgrade Neutral
(Outperform)		 N/A
(N/A)		 4.79
(4.92)		 2.71% Details
4/26/2019 H.C. Wainwright N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.43
(4.92)		 43.44% Details